Skip to main content
SpringerLink
Log in

Advantage of landiolol over esmolol? We doubt it!

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Krumpl G, Ulc I, Trebs M, Kadlecova P, Hodisch J (2017) Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol 73(4):417–428. https://doi.org/10.1007/s00228-016-2176-0

    Article  CAS  PubMed  Google Scholar 

  2. Nasrollahi-Shirazi S, Sucic S, Yang Q, Freissmuth M, Nanoff C (2016) Comparison of the beta-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions. J Pharmacol Exp Ther 359(1):73–81. https://doi.org/10.1124/jpet.116.232884

    Article  CAS  PubMed  Google Scholar 

  3. Shibata S, Okamoto Y, Endo S, Ono K (2012) Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J Pharmacol Sci 118(2):255–265

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesia and Intensive Care Medicine, Landesklinikum Horn, 3580, Horn, Austria

    Guenther Frank

  2. Karl Landsteiner Institute for Anaesthesiology and Intensive Care Medicine, 1130, Vienna, Austria

    Robert Denham Fitzgerald

Authors
  1. Guenther Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Denham Fitzgerald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guenther Frank.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frank, G., Fitzgerald, R.D. Advantage of landiolol over esmolol? We doubt it!. Eur J Clin Pharmacol 74, 671–672 (2018). https://doi.org/10.1007/s00228-017-2408-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2408-y

Search

Navigation